Brief: Apimeds And Mindwave Announce Merger, Integrating Biotech Growth With AI
01/12/2025 14:27
Dec 1 (Reuters) - Apimeds Pharmaceuticals US Inc APUS.A: APIMEDS AND MINDWAVE ANNOUNCE MERGER, INTEGRATING BIOTECH GROWTH WITH AI-DRIVEN DIGITAL TREASURY YIELD GENERATION BACKED BY $100M PIPE Source text: ID:nBwyT5Lra Further company coverage: APUS.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Apimeds Pharmaceuticals US
See all newsBrief: Mindwave Innovations Signs 3 Client Network Agreements In 10 Days, Extending Mindchain Into Climate Finance, Sports Media And Insurance Apimeds Pharmaceuticals Us Provides Required NYSE American Disclosure
Brief: Apimeds Pharmaceuticals US Enters Assignment And Transfer Agreement With Freet On August 19
Brief: Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer
Brief: Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board
Brief: Apimeds Pharmaceuticals Us Inc. Announces Material Breach Of Merger Agreement By Inscobee Inc And Apimeds Inc